Invention Grant
- Patent Title: Recombinant anti-VLA4 antibody molecules
- Patent Title (中): 重组抗VLA4抗体分子
-
Application No.: US12338570Application Date: 2008-12-18
-
Publication No.: US07829092B2Publication Date: 2010-11-09
- Inventor: Roy R. Lobb , Frank J. Carr , Philip R. Tempest
- Applicant: Roy R. Lobb , Frank J. Carr , Philip R. Tempest
- Applicant Address: US MA Cambridge
- Assignee: Biogen Idec MA Inc.
- Current Assignee: Biogen Idec MA Inc.
- Current Assignee Address: US MA Cambridge
- Agency: Steptoe & Johnson LLP
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/28 ; C12N15/13 ; C12N5/10 ; C12N15/00
Abstract:
The present invention disclosed recombinant anti-VLA-4 antibody molecules, including humanized recombinant anti-VLA-4 antibody molecules. These antibodies are useful in the treatment of specific and non-specific inflammation, including asthma and inflammatory bowel disease. In addition, the humanized recombinant anti-VLA-4 antibodies disclosed can be useful in methods of diagnosing and localizing sites of inflammation.
Public/Granted literature
- US20100203042A1 RECOMBINANT ANTI-VLA4 ANTIBODY MOLECULES Public/Granted day:2010-08-12
Information query
